Chris Luoma, Senior Vice President and Chief Strategy Officer, GHX Advancements in medical technology have increased the demand for surgical implants. These implants, such as artificial joints and heart valves, pacemakers, ventricular shunts and cochlear implants, have revolutionized how doctors treat patients, helping them live better, more fulfilling lives.
The implantable device market is projected to reach $166.3 billion by 2032. Although this growth is exciting, it also highlights the need for healthcare to transform digitally.
Implant orders currently account for approximately 10 percent of all purchase orders, representing 40 to 60 percent of supply chain spend. Today, only a tiny […]
Full Post at hitconsultant.net